The Massachusetts Life Sciences Center this week announced the addition of Jonathan Fleming, Doug Cole, and Jean George to the organization’s scientific advisory board, bringing the board’s total membership to fifteen.
Fleming is the managing general partner of Oxford Bioscience Partners. Prior to joining OBP in 1996, he was a founding general partner of MVP Ventures. He began his investment career with TVM Techno Venture Management. Fleming also co-founded Medica Venture Partners.
Cole is currently a general partner at Flagship Ventures. While at Flagship, Cole co-founded Ensemble Discovery with Noubar Afeyan and David Liu of Harvard University, and he served as chief executive officer of the company its initial stages.
He was previously medical director of Cytotherapeutics. Cole was then appointed program executive at Vertex Pharmaceuticals.
Jean George is a partner at Advanced Technology Ventures. Prior to joining ATV, George was a director at BancBoston Ventures. Previously, George held a variety of roles in marketing, product development, and business development at Genzyme, including vice president of global sales and marketing.